Sakamoto M

No ORCID on file · 7 papers in corpus · active 1987-2025

Study types

  • other 2

Condition tags

  • endometriosis 2
2025
Journal of clinical medicine ·doi:10.3390/jcm14248892

Background: Assisted reproductive therapy (ART) has been utilized as an effective therapeutic strategy for addressing infertility worldwide, and one of the key determinants of ART success is the acquisition of high-quality embryos through i…

2024
Cureus ·doi:10.7759/cureus.54512

A surgical technique has been developed using a robot-assisted system to create the surgical anatomical structure of the uterine artery caudal space (UACS), a landmark for performing extrafascial hysterectomy, enabling a safe and easy param…

2021
Reproduction & fertility ·doi:10.1530/raf-20-0030

PurposeFollowing reports of an increase in implantation and pregnancy continuation rates by a higher percentage of Lactobacillus in the intrauterine microbiota, it has received attention in infertility treatment. This study aimed to examine…

2017
Gynecology and Minimally Invasive Therapy ·doi:10.1016/j.gmit.2016.12.001

Study objectiveTo describe Higuchi's transverse incision and a modification of this method for reduced port surgery (RPS).DesignDescriptive study.SettingUniversity hospital.PatientsThose with ovarian cyst and uterine myoma.InterventionA pla…

2003
The American Journal of Pathology ·doi:10.1016/s0002-9440(10)63605-x

Of all of the epithelial ovarian cancers, clear cell carcinoma (CCC) of the ovary has the worst prognosis. We applied the oligonucleotide array technique to identify genes generally involved in CCC. Of the approximately 12,600 genes that we…

other 1993
Gynecologic oncology ·doi:10.1006/gyno.1993.1026

Serum levels of cancer-associated antigen 72-4 (CA72-4) (tumor-associated glycoprotein 72; TAG-72) from 106 patients with primary ovarian cancer were measured by an immunoradiometric assay employing the monoclonal antibodies (MAbs) B72.3 an…

other 1987
Gynecologic and obstetric investigation ·doi:10.1159/000298862

The serum levels of CA 125 and CA 19-9 were determined by an immunoradiometric assay employing the monoclonal antibody OC 125 and anti-CA 19-9 antibody in 88 patients with ovarian carcinoma. When a cut-off value of CA 125 was set below 35 U…